JCCT 227

The purpose of this study is to compare the effects, good or bad, of low to high doses of CT-388 against placebo (a placebo looks like a drug but has no active ingredient) in people living with overweight or obesity and T2D. The effects of CT-388 on body weight and blood sugar levels will be assessed to find the best dose(s) for achieving weight loss, control of T2D, and to evaluate the safety of CT-388 versus placebo.

JCCT 225

The purpose of this study is to look at a study vaccine, called PG4, given with adjuvants, that may be used to extend protection against pneumococcal disease due to a germ called S. pneumoniae.

JCCT 224

In this study, we will test a new influenza (flu) vaccine called the “Flu seasonal mRNA vaccine”. The investigational vaccine is designed to work against the influenza virus. This study is being done to test whether the new study vaccine is safe and how the human body reacts to it. 

JCCT 221

The purpose of this study is to assess the safety of different doses of CRV-101 and its effect on the immune system in comparison to SHINGRIX®, an FDA approved Shingles vaccine, in adults aged 50 years and older.

JCCT 218

The purpose of this research study is to test an experimental drug called ORMD-0801, an orally administered formulation of insulin.

JCCT 209

The study is aiming to test an investigational vaccine developed to prevent urinary tract infections caused by the bacterium E. coli.

JCCT 211

The purpose of this study is to compare 2 different study vaccine doses by evaluating immune system responses (the body’s defense system) and reactions after the study vaccinations. In addition, this study will compare the reactions following the vaccination with the MVA‑BN‑WEV study vaccine or placebo.

JCCT 216

The purpose of this research is to assess the safety and efficacy of IMM01-STEM in senior participants with muscle weakness and obesity (Sarcopenic Obesity).

JCCT 222

We are doing this study to learn more about treatments that could reduce the risk of developing heart failure, reduce the risk of death from cardiovascular causes and also to better understand the studied disease and associated health problems.